BeOne Medicines AG
ONC
$316.99
-$5.38-1.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.50M | 124.84M | 94.32M | 1.27M | -151.88M |
| Total Depreciation and Amortization | 34.44M | 35.75M | 29.87M | 31.63M | 49.06M |
| Total Amortization of Deferred Charges | 16.42M | 1.54M | 5.75M | 1.17M | 1.18M |
| Total Other Non-Cash Items | 136.44M | 140.41M | 128.31M | 88.04M | 195.66M |
| Change in Net Operating Assets | 163.55M | 100.02M | 5.35M | -78.03M | -18.86M |
| Cash from Operations | 417.35M | 402.55M | 263.60M | 44.08M | 75.16M |
| Capital Expenditure | -37.52M | -48.08M | -43.83M | -56.41M | -92.48M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -813.00K | -1.19M | -22.78M | -65.53M | -1.13M |
| Cash from Investing | -38.34M | -49.27M | -66.61M | -121.94M | -93.61M |
| Total Debt Issued | 862.74M | 0.00 | 141.52M | 80.00M | 543.86M |
| Total Debt Repaid | -783.62M | -4.26M | -115.45M | -177.14M | -557.18M |
| Issuance of Common Stock | 19.24M | 80.54M | 33.14M | 63.36M | 8.80M |
| Repurchase of Common Stock | 0.00 | 0.00 | -24.20M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.44M | 885.00M | -- | -- | 0.00 |
| Cash from Financing | 96.93M | 961.27M | 35.03M | -33.78M | -4.52M |
| Foreign Exchange rate Adjustments | 23.16M | 9.91M | 23.48M | 3.48M | -51.71M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 499.11M | 1.32B | 255.50M | -108.16M | -74.68M |